NervGen Pharma Corp. Common stock
NGEN | NASDAQ
$1.41
+$0.04 (+2.92%)
Nov 2, 2026, 2:34 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 | Q2 2023 Jun 30, 2023 | Q1 2023 Mar 31, 2023 | Q4 2022 Dec 31, 2022 | Q3 2022 Sep 30, 2022 | Q2 2022 Jun 30, 2022 | Q1 2022 Mar 31, 2022 | Q4 2021 Dec 31, 2021 | Q3 2021 Sep 30, 2021 | Q2 2021 Jun 30, 2021 | Q1 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 12.52K | 12.21K | 11.9K | 57.65K | 58.31K | 59.31K | 83.82K | 106.64K | 128.52K | 148.49K | 144.87K | 140.69K | 138.61K | 137.84K | 114.45K | 88.89K | 63.1K | 39.44K | 38.05K | 39.16K | 40.48K | 39.86K |
Gross Profit | -12.52K | -12.21K | -11.9K | -57.65K | -58.31K | -59.31K | -83.82K | -106.64K | -128.52K | -148.49K | -144.87K | -140.69K | -138.61K | -137.84K | -114.45K | -88.89K | -63.1K | -39.44K | -38.05K | -39.16K | -40.48K | -39.86K |
Operating Income | -38.06M | -32.04M | -30.38M | -25.48M | -26.52M | -26.01M | -24.99M | -23.06M | -19.25M | -18.03M | -17.76M | -19.61M | -21.09M | -22.63M | -22.91M | -19.48M | -17.51M | -13.96M | -11.19M | -12.33M | -11.46M | -11.14M |
Interest Income | 507.58K | 409.68K | 411.02K | 442.64K | 608.74K | 816.09K | 812.08K | 763.64K | 656.48K | 501.31K | 549.58K | 512.28K | 440.06K | 334.08K | 199.99K | 124.92K | 66.23K | 38.03K | 25.4K | 20.12K | 18.91K | 14.74K |
Pretax Income | -67.56M | -46.72M | -48.94M | -25.84M | -26.96M | -25.64M | -24.06M | -24.07M | -23.07M | -20.01M | -22.37M | -19.65M | -18.82M | -20.38M | -20.63M | -18.03M | -17.42M | -13.84M | -11.12M | -12.42M | -11.68M | -11.56M |
Net Income | -67.56M | -46.72M | -48.94M | -25.84M | -26.96M | -25.64M | -24.06M | -24.07M | -23.07M | -20.01M | -22.37M | -19.65M | -18.82M | -20.38M | -20.63M | -18.03M | -17.42M | -13.84M | -11.12M | -12.42M | -11.68M | -11.56M |
Selling & General & Admin | 14.04M | 13.39M | 13.54M | 10.57M | 11.65M | 10.07M | 9.19M | 9.16M | 8.9M | 9.93M | 9.62M | 9.1M | 8.26M | 6.58M | 6.31M | 5.92M | 5.53M | 5.18M | 5.26M | 5.11M | 5.13M | 5.32M |
Research & Development | 24.01M | 18.64M | 16.83M | 14.85M | 14.81M | 15.88M | 15.72M | 13.8M | 10.22M | 7.95M | 8M | 10.37M | 12.69M | 15.92M | 16.49M | 13.47M | 11.91M | 8.74M | 5.89M | 7.17M | 6.29M | 5.79M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 38.05M | 32.03M | 30.37M | 25.42M | 26.46M | 25.95M | 24.91M | 22.96M | 19.13M | 17.88M | 17.62M | 19.47M | 20.95M | 22.49M | 22.8M | 19.39M | 17.45M | 13.92M | 11.16M | 12.29M | 11.42M | 11.1M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 509.74K | 509.74K | 509.74K | 509.74K | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 38.06M | 32.04M | 30.38M | 25.48M | 26.52M | 26.01M | 24.99M | 23.06M | 19.25M | 18.03M | 17.76M | 19.61M | 21.09M | 22.63M | 22.91M | 19.48M | 17.51M | 13.96M | 11.19M | 12.33M | 11.46M | 11.14M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 92.44M | 79.9M | 72.33M | 73.16M | 71.96M | 70.67M | 70.33M | 70.07M | 69.95M | 60.21M | 59.61M | 59.42M | 59.22M | 58.96M | 58.78M | 58.16M | 47.3M | 46.23M | 46.08M | 40.13M | 37.65M | 35.46M |
Shares Outstanding (Diluted) | 92.44M | 79.9M | 72.33M | 73.16M | 71.96M | 70.67M | 70.33M | 70.07M | 69.95M | 60.21M | 59.61M | 59.42M | 59.22M | 58.96M | 58.78M | 58.16M | 47.3M | 46.23M | 46.08M | 40.13M | 37.65M | 35.46M |
EPS (Basic) | -0.85 | -0.65 | -0.68 | -0.36 | -0.38 | -0.36 | -0.34 | -0.37 | -0.37 | -0.34 | -0.38 | -0.33 | -0.32 | -0.37 | -0.40 | -0.37 | -0.38 | -0.33 | -0.28 | -0.34 | -0.33 | -0.34 |
EPS (Diluted) | -0.85 | -0.65 | -0.68 | -0.36 | -0.38 | -0.36 | -0.34 | -0.37 | -0.37 | -0.34 | -0.38 | -0.33 | -0.32 | -0.37 | -0.40 | -0.37 | -0.38 | -0.33 | -0.28 | -0.34 | -0.33 | -0.34 |
EBITDA | -11.61M | -8.24M | -10.46M | -25.78M | -26.91M | -25.58M | -23.98M | -23.96M | -22.94M | -19.86M | -22.22M | -19.5M | -18.17M | -19.73M | -20M | -17.43M | -17.36M | -13.8M | -11.08M | -12.38M | -11.64M | -11.52M |
EBIT | -11.68M | -8.31M | -10.53M | -25.84M | -26.96M | -25.64M | -24.06M | -24.07M | -23.07M | -20.01M | -22.37M | -19.65M | -18.31M | -19.87M | -20.12M | -17.52M | -17.42M | -13.84M | -11.12M | -12.42M | -11.68M | -11.56M |
Depreciation & Amortization | 68.31K | 68.01K | 67.7K | 57.65K | 58.31K | 59.31K | 83.82K | 106.64K | 128.52K | 148.49K | 144.87K | 140.69K | 138.61K | 137.84K | 114.45K | 88.89K | 63.1K | 39.44K | 38.05K | 39.16K | 40.48K | 39.86K |
Add to Watchlist
Select watchlists to add or remove NGEN